(Applause) The data that we presented to FDA from 107 people in our pilot studies, including Tony, showed that 23 percent of the people that received therapy without active MDMA no longer had PTSD at the end of treatment.
(Aplausos) Os dados que apresentamos à FDA de 107 pessoas em nossos estudos-piloto, inclusive Tony, mostraram que 23% delas que receberam terapia sem MDMA ativa não sofriam mais de TEPT no final do tratamento.